Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 2764261, 6 pages
https://doi.org/10.1155/2017/2764261
Research Article

Elevated Plasma Levels of sIL-2R in Complex Regional Pain Syndrome: A Pathogenic Role for T-Lymphocytes?

1Center for Pain Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands
2Department of Immunology, Laboratory Medical Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands

Correspondence should be addressed to Krishna D. Bharwani

Received 15 February 2017; Accepted 3 May 2017; Published 28 May 2017

Academic Editor: Amedeo Amedei

Copyright © 2017 Krishna D. Bharwani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. N. Harden, S. Bruehl, R. S. Perez et al., “Validation of proposed diagnostic criteria (the “Budapest criteria”) for complex regional pain syndrome,” Pain, vol. 150, no. 2, pp. 268–274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. de Mos, A. G. de Bruijn, F. J. Huygen, J. P. Dieleman, B. H. Stricker, and M. C. Sturkenboom, “The incidence of complex regional pain syndrome: a population-based study,” Pain, vol. 129, no. 1-2, pp. 12–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Bruehl, “An update on the pathophysiology of complex regional pain syndrome,” Anesthesiology, vol. 113, no. 3, pp. 713–725, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Bruehl, C. Maihöfner, M. Stanton-Hicks et al., “Complex regional pain syndrome: evidence for warm and cold subtypes in a large prospective clinical sample,” Pain, vol. 157, no. 8, pp. 1674–1681, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Schattschneider, K. Hartung, M. Stengel et al., “Endothelial dysfunction in cold type complex regional pain syndrome,” Neurology, vol. 67, no. 4, pp. 673–675, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. G. M. Ribbers, W. P. Oosterhuis, J. van Limbeek, and M. de Metz, “Reflex sympathetic dystrophy: is the immune system involved?” Archives of Physical Medicine and Rehabilitation, vol. 79, no. 12, pp. 1549–1552, 1998. View at Publisher · View at Google Scholar
  7. C. Schinkel, A. Gaertner, J. Zaspel, S. Zedler, E. Faist, and M. Schuermann, “Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome,” The Clinical Journal of Pain, vol. 22, no. 3, pp. 235–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Schinkel, A. Scherens, M. Köller, G. Roellecke, G. Muhr, and C. Maier, “Systemic inflammatory mediators in post-traumatic complex regional pain syndrome (CRPS I) - longitudinal investigations and differences to control groups,” European Journal of Medical Research, vol. 14, no. 3, pp. 130–135, 2009. View at Publisher · View at Google Scholar
  9. P. H. Veldman, H. M. Reynen, I. E. Arntz, and R. J. Goris, “Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients,” Lancet, vol. 342, no. 8878, pp. 1012–1016, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. M. de Mos, M. C. Sturkenboom, and F. J. Huygen, “Current understandings on complex regional pain syndrome,” Pain Practice, vol. 9, no. 2, pp. 86–99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. F. J. Huygen, A. G. De Bruijn, M. T. De Bruin, J. G. Groeneweg, J. Klein, and F. J. Zijlstra, “Evidence for local inflammation in complex regional pain syndrome type 1,” Mediators of Inflammation, vol. 11, no. 1, pp. 47–51, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Wesseldijk, F. J. Huygen, C. Heijmans-Antonissen, S. P. Niehof, and F. J. Zijlstra, “Tumor necrosis factor-alpha and interleukin-6 are not correlated with the characteristics of complex regional pain syndrome type 1 in 66 patients,” European Journal of Pain, vol. 12, no. 6, pp. 716–721, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Uceyler, T. Eberle, R. Rolke, F. Birklein, and C. Sommer, “Differential expression patterns of cytokines in complex regional pain syndrome,” Pain, vol. 132, no. 1-2, pp. 195–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Goebel and F. Blaes, “Complex regional pain syndrome, prototype of a novel kind of autoimmune disease,” Autoimmunity Reviews, vol. 12, no. 6, pp. 682–686, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Dirckx, M. W. Schreurs, M. de Mos, D. L. Stronks, and F. J. Huygen, “The prevalence of autoantibodies in complex regional pain syndrome type I,” Mediators of Inflammation, vol. 2015, Article ID 718201, 5 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. N. R. Rose and C. Bona, “Defining criteria for autoimmune diseases (Witebsky’s postulates revisited),” Immunology Today, vol. 14, no. 9, pp. 426–430, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Sommer, “Anti-autonomic nervous system antibodies in CRPS,” Pain, vol. 152, no. 12, pp. 2675-2676, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Blaes, K. Schmitz, M. Tschernatsch et al., “Autoimmune etiology of complex regional pain syndrome (M. Sudeck),” Neurology, vol. 63, no. 9, pp. 1734–1736, 2004. View at Publisher · View at Google Scholar
  19. A. Goebel, M. I. Leite, L. Yang et al., “The passive transfer of immunoglobulin G serum antibodies from patients with longstanding complex regional pain syndrome,” European Journal of Pain, vol. 15, no. 5, p. 504, 2011, e1-6. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Kaufmann, C. Eisner, P. Richter et al., “Lymphocyte subsets and the role of TH1/TH2 balance in stressed chronic pain patients,” Neuroimmunomodulation, vol. 14, no. 5, pp. 272–280, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Osborne, J. Farrell, R. J. Dearman et al., “Cutaneous immunopathology of long-standing complex regional pain syndrome,” European Journal of Pain, vol. 19, no. 10, pp. 1516–1526, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Caruso, G. Candore, D. Cigna, A. T. Colucci, and M. A. Modica, “Biological significance of soluble IL-2 receptor,” Mediators of Inflammation, vol. 2, no. 1, pp. 3–21, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. S. L. Gaffen and K. D. Liu, “Overview of interleukin-2 function, production and clinical applications,” Cytokine, vol. 28, no. 3, pp. 109–123, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. Witkowska, “On the role of sIL-2R measurements in rheumatoid arthritis and cancers,” Mediators of Inflammation, vol. 2005, no. 3, pp. 121–130, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. L. A. Rubin, C. C. Kurman, M. E. Fritz et al., “Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro,” Journal of Immunology, vol. 135, no. 5, pp. 3172–3177, 1985. View at Google Scholar
  26. L. A. Rubin, F. Galli, W. C. Greene, D. L. Nelson, and G. Jay, “The molecular basis for the generation of the human soluble interleukin 2 receptor,” Cytokine, vol. 2, no. 5, pp. 330–336, 1990. View at Publisher · View at Google Scholar · View at Scopus
  27. L. A. Rubin, K. M. Snow, C. C. Kurman, D. L. Nelson, and E. C. Keystone, “Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity,” The Journal of Rheumatology, vol. 17, no. 5, pp. 597–602, 1990. View at Google Scholar
  28. J. C. Grutters, J. M. Fellrath, L. Mulder, R. Janssen, J. M. van den Bosch, and H. van Velzen-Blad, “Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation,” Chest, vol. 124, no. 1, pp. 186–195, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. A. D. Vorselaars, C. H. van Moorsel, P. Zanen et al., “ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy,” Respiratory Medicine, vol. 109, no. 2, pp. 279–285, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Muller-Quernheim, “Sarcoidosis: clinical manifestations, staging and therapy (part II),” Respiratory Medicine, vol. 92, no. 2, pp. 140–149, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Bruehl, R. N. Harden, B. S. Galer et al., “External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria. International Association for the Study of Pain,” Pain, vol. 81, no. 1-2, pp. 147–154, 1999. View at Google Scholar
  32. G. M. Alexander, B. L. Peterlin, M. J. Perreault, J. R. Grothusen, and R. J. Schwartzman, “Changes in plasma cytokines and their soluble receptors in complex regional pain syndrome,” The Journal of Pain, vol. 13, no. 1, pp. 10–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Gotoh, Y. Okamoto, O. Uemura et al., “Determination of age-related changes in human soluble interleukin 2 receptor in body fluids of normal subjects as a control value against disease states,” Clinica Chimica Acta, vol. 289, no. 1-2, pp. 89–97, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. D. J. Giannitsis, B. Muller-Hof, and B. Hacker-Shahin, “Serum soluble interleukin-2 receptor levels of normal blood donors,” Cytobios, vol. 68, no. 274-275, pp. 161–164, 1991. View at Google Scholar
  35. M. N. Manoussakis, E. D. Stavropoulos, G. S. Germanidis et al., “Soluble interleukin-2 receptors and autoantibodies in the serum of healthy elderly individuals,” Autoimmunity, vol. 7, no. 2-3, pp. 129–137, 1990. View at Google Scholar